While medicinal cannabis is federally legal in Canada, patients, until now, had to order from one of the licensed producers (LPs) and wait for it to arrive in the mail as directed by Health Canada rules, which require the LP to “use a shipping method that ensures the tracking and safekeeping of the package during transportation.” Today, two of the LPs, Aurora Cannabis and  Bedrocan Canada, part of Canopy Growth, announced that they will now offer same-day delivery within certain geographies.

Aurora Cannabis issued a press release explaining its new policy, which, effective immediately, allows same-day delivery for orders placed before noon to residents of Calgary and surrounding areas.  In June, the service will expand to Edmonton and surrounding areas. The company was required to develop customized software in order to integrate with its ERP software.

We are very proud to bring this innovative commitment to our customers, and by next month we will be able to offer same-day delivery to an area covering the majority of the population of Alberta.

Neil Belot, Chief Brand Officer of Aurora Cannabis

Our objective has always been to provide the best client care in the industry, ensuring patients have fast, hassle-free access to a broad range of the highest quality cannabis products. This is yet another manifestation of the Aurora Standard, our promise to drive innovation and continuously enhance the experience of our customers.

In its press release, Canopy Growth announced that beginning May 26th, it will deliver orders to patients in Toronto by 8PM if they are placed before noon.

Torontonians who are seeking a reliable supply of medical cannabis can now turn to the most affordable solution in the City, delivered same-day to their door, and rest assured there is no question about the legality and origins of their cannabis supply.

Bruce Linton, CEO of Canopy Growth

Working with partners like Canadian Cannabis Clinics, we can ensure that any patient who requires access to doctors specializing in cannabis as a treatment, can find the support they need to access the legal system where medically appropriate.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email